| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/16/2006 | US20060059581 Method of breeding glyphosate resistant plants |
| 03/16/2006 | US20060059579 Model animals non-responsive to mycobacteria-origin lipoprotein/lipopeptide |
| 03/16/2006 | US20060059578 Adiponectin-knoucout nonhuman animal |
| 03/16/2006 | US20060059577 Melusin a muscle specific protein, as a drug target for prevention and treatment of heart failure |
| 03/16/2006 | US20060059576 Treatment of neurodegenerative conditions with nimesulide |
| 03/16/2006 | US20060059575 Method for preparing monoclonal antibody |
| 03/16/2006 | US20060058967 Method of designing probe set, microarray having substrate on which probe designed by the method is immobilized, and computer readable medium on which program for executing the method is recorded |
| 03/16/2006 | US20060058519 Isolation of nucleic acid |
| 03/16/2006 | US20060058516 Novel serine-threonine kinase |
| 03/16/2006 | US20060058512 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060058510 Lipocalins having a cylindrical beta-pleated sheet of eight beta -strands connected pair-wise by four peptide loops to define a bindingpocket; sequences of bilin-binding protein of Pieris brassicae; genetic engineering; mutants; small chemical, peptide epitopes with determinable affinity >105 M-1 |
| 03/16/2006 | US20060058505 Nucleic acid and polypeptide linked to breast cancer and uses therefor |
| 03/16/2006 | US20060058369 Therapeutic methods employing PAI-1 inhibitors and transgenic non-human animal for screening candidate PAI-1 inhibitors |
| 03/16/2006 | US20060058258 Gene transcription and ionizing radiation: methods and compositions |
| 03/16/2006 | US20060058256 Capable of inducing breakdown of mrna enzymes that break down connective tissue; particularly suited for treating degenerative skin disorders; pharmaceutical and cosmetic compositions for topical application and which contain the oligoribonucleotides |
| 03/16/2006 | US20060058255 RNAi-based therapeutics for allergic rhinitis and asthma |
| 03/16/2006 | US20060058254 Immunostimulatory sequence oligonucleotides and methods of using the same |
| 03/16/2006 | US20060058253 Methods to reprogram splice site selection in pre-messenger rnas |
| 03/16/2006 | US20060058252 Methods and materials for treating human papillomavirus infections |
| 03/16/2006 | US20060058251 Use of immunostimulatory nucleic acids containing unmethylated CpG dinucleotide sequences to treat viral infections; use with viral antigen in vaccine or without a viral antigen |
| 03/16/2006 | US20060058249 Efficient nucleic acid encapsulation into medium sized liposomes |
| 03/16/2006 | US20060058239 Use of the insulin-like-growth factor I isoform MGF for the treatment of neurological disorders |
| 03/16/2006 | US20060058190 Malate dehydrogenase as a target for herbicides |
| 03/16/2006 | US20060058189 Ftsz-polypeptides as a target for herbicidal compounds |
| 03/16/2006 | US20060057726 Method for the positive selection of chromosomal mutations in C1 metabolizing bacteria via homologous recombination |
| 03/16/2006 | US20060057725 Therapeutic retroviral vectors for gene therapy |
| 03/16/2006 | US20060057724 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics and phenotypes |
| 03/16/2006 | US20060057723 Transgenic plants containing molecular decoys that alter protein content therein |
| 03/16/2006 | US20060057720 Mesenchymal cells derived from human embryonic stem cells |
| 03/16/2006 | US20060057719 Carbohydrate determinant selection system for homologous recombination |
| 03/16/2006 | US20060057714 Vector |
| 03/16/2006 | US20060057706 Electroporation device |
| 03/16/2006 | US20060057700 Using glycosylated pilin as diagnostic indicator and preventative initation in treating pseudomonal infections; immunotherapy; glycosylated with the O-antigen; Pseudomonas aeruginosa; Escherichia coli |
| 03/16/2006 | US20060057698 Nucleic acids and polypeptides involved in the production of cryptophycin |
| 03/16/2006 | US20060057697 Transfers a D-glucuronic acid residue to an N-acetyl-D-galactosamine residue when the N-acetyl-D-galactosamine residue is present at the non-reducing end of the chondroitin backbone, or transfers an N-acetyl-D-galactosamine residue to a D-glucuronic acid residue |
| 03/16/2006 | US20060057696 Sugar chain synthases |
| 03/16/2006 | US20060057695 GANP protein |
| 03/16/2006 | US20060057694 Rat receptor tyrosine knase, kdr |
| 03/16/2006 | US20060057690 Glycerol-3-phosphate o-acyltransferase promoter for gene expression in oleaginous yeast |
| 03/16/2006 | US20060057687 Changing the fine chemical content in organisms by genetically modifying the shikimate pathway |
| 03/16/2006 | US20060057683 The unligatable open plasmid is converted to 3'-hydroxyl, 5'-phosphate nicked plasmid, reacted with a DNA ligase to convert to relaxed covalently closed circular plasmid, reacting with DNA gyrase, purifying; improved stability during preparation |
| 03/16/2006 | US20060057682 Mutation of dna polymerases from archaeobacteria |
| 03/16/2006 | US20060057677 Organic anion transporter and gene coding for the same |
| 03/16/2006 | US20060057676 which are induced by fermentable glucose or non-fermentable ethanol |
| 03/16/2006 | US20060057674 Translocating enzyme as a selection marker |
| 03/16/2006 | US20060057672 Exo-endo cellulase fusion protein |
| 03/16/2006 | US20060057669 Inactive transcription factor tif-ia and uses thereof |
| 03/16/2006 | US20060057668 Antimicrobial polypeptide and utilization thereof |
| 03/16/2006 | US20060057666 Human g protein coupled receptor |
| 03/16/2006 | US20060057665 Galectin-14 therapeutic molecule and uses thereof |
| 03/16/2006 | US20060057664 Polypeptides and polynucleotides encoding same |
| 03/16/2006 | US20060057663 Novel g protein-coupled receptor protein and dna thereof |
| 03/16/2006 | US20060057662 Membrane scaffold proteins |
| 03/16/2006 | US20060057648 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) |
| 03/16/2006 | US20060057645 Novel genes |
| 03/16/2006 | US20060057641 Having T cell stimulatory activity of a dog dander allergen, therapy |
| 03/16/2006 | US20060057633 Methods of creating modified promoters resulting in varying levels of gene expression |
| 03/16/2006 | US20060057632 Artificial antibody library with super-repertory |
| 03/16/2006 | US20060057617 Amplification process |
| 03/16/2006 | US20060057610 System for producing synthetic promoters |
| 03/16/2006 | US20060057607 Small RNAs and bacterial strains involved in quorum sensing |
| 03/16/2006 | US20060057606 Reagents containing terminal-phosphate-labeled nucleotides for nucleic acid sequencing |
| 03/16/2006 | US20060057605 Compositions for use in identification of viral hemorrhagic fever viruses |
| 03/16/2006 | US20060057589 Identification and detection of algae species, strains and toxins |
| 03/16/2006 | US20060057584 Endometriosis-related markers and uses thereof |
| 03/16/2006 | US20060057583 Novel compositions and methods for controlling the extendability of various components used in copying or amplification steps |
| 03/16/2006 | US20060057579 Method for predicting a drug transport capability by abcg2 polymorphisms |
| 03/16/2006 | US20060057575 Method for two-dimensional conformation-dependent separation of non-circular nucleic acids |
| 03/16/2006 | US20060057574 Tissue specific expression |
| 03/16/2006 | US20060057573 Methods and reagents for detecting target binding by nucleic acid ligands |
| 03/16/2006 | US20060057572 Designing primers based on information obtained from a part of genes of the specified substance; performing polymerase chain reaction; detecting a trace component contained in a food or identifying a specific harmful allergen |
| 03/16/2006 | US20060057570 Antisense modulation of hematopoietic cell protein tyrosine kinase expression |
| 03/16/2006 | US20060057569 Method for detecting hybridization events in nucleic acids |
| 03/16/2006 | US20060057567 Method for constructing a chimeric dna library using a single strand speific dnase |
| 03/16/2006 | US20060057562 Method, composition and kit for antigenic binding of norwalk-like viruses |
| 03/16/2006 | US20060057561 Virus detection method, primers therefor and screening kit |
| 03/16/2006 | US20060057553 Chimeric viral vectors for gene therapy |
| 03/16/2006 | US20060057194 introducing a biologically active agent into a cell of a plant or animal comprising: contacting said cell with lipid vesicles comprising amino acid amide lipids in vivo or in vitro; gene therapy |
| 03/16/2006 | US20060057193 Delivery system for pharmaceutical agents |
| 03/16/2006 | US20060057160 Vaccine composition |
| 03/16/2006 | US20060057158 Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines |
| 03/16/2006 | US20060057156 Materials and methods for inductions of immune tolerance |
| 03/16/2006 | US20060057155 Adp-ribosylating bacterial toxins |
| 03/16/2006 | US20060057146 Selective targeting of tumor vasculature using antibody molecules |
| 03/16/2006 | US20060057139 Process for producing humanized chimera antibody |
| 03/16/2006 | US20060057130 An isolated RNA-pulsed antigen presenting cell comprising tumor specific RNA; stimulation of cytotoxic T-lymphocyte proliferation ex vivo or in vivo for adoptive immunotherapy; anticarcinogenic agents; antitumor agents; bactericides; viricides |
| 03/16/2006 | US20060057117 Vascular endothelial growth factor 2 |
| 03/16/2006 | US20060057116 Recombinant influenza viruses for vaccines and gene therapy |
| 03/16/2006 | US20060057115 Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof |
| 03/16/2006 | US20060057114 Preventing/inhibiting metabolic disorders characterized by absence or reduced levels of alpha-L-iduronidase in newborn mammals by administering recombinant lentivirus comprising nucleic acid segment encoding alpha-L-iduronidase |
| 03/16/2006 | US20060057113 Novel adenoviruses, nucleic acids coding therefor, and use thereof |
| 03/16/2006 | US20060057112 Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances and uses thereof |
| 03/16/2006 | US20060057072 Method for diagnosis and treatment of vascular disease |
| 03/16/2006 | US20060057032 Substrate plate, method and apparatus for manufacturing such a substrate plate, and system for conducting biossays comprising such a substrate plate |
| 03/16/2006 | DE19943383B4 Regulatorische Sequenzen und Expressionskassetten für Hefen Regulatory sequences and expression cassettes for yeasts |
| 03/16/2006 | DE102004043748A1 Biokatalysator zur Hydrolyse von Cyanid Hydrolysis of biocatalyst for cyanide |
| 03/16/2006 | DE102004041717A1 Modifying fermentation process on an industrial scale by use of a gene and its by-products derived from Bacillus licheniformis |
| 03/16/2006 | DE102004037611A1 Induzierbare Genexpression Inducible gene expression |
| 03/16/2006 | DE102004035687A1 Isoliertes Photoprotein Aequorin Y89F, sowie dessen Verwendung The isolated photoprotein aequorin Y89F, and its use |
| 03/16/2006 | DE102004035337A1 Varianten der Gruppe 1-Allergene aus Poaceae mit reduzierter Allergenität und erhaltener T-Zellreaktivität Variants of the group 1 allergens from Poaceae with reduced allergenicity and preserved T cell reactivity |